SMAD3 and neoplasm: These findings indicate that SMAD3 likely plays a role in PLEXIND1-mediated tumor development, and fits with our model; namely, in PANC-1 cells, PLEXIND1 knockdown leads to SMAD3 downregulation, and the lack of both PLEXIND1 and SMAD3 individually impair tumor growth and development.